Live
- 6th World Telugu Writers meet from Dec 28
- Sri City role in strengthening Atmanirbhar Bharat lauded
- PCC chief accuses PM of lying on Visakha steel
- Vaikunta Dwara Darshan: Only those with tokens, tickets to be allowed
- Bandi Sanjay visits aspirational block in Narayanpet
- YSRCP calls for statewide protests today
- Power Tariff Hike: Jagan’s protests nothing but hypocrisy says Minister
- Pawan Kalyan condoles death of Manmohan Singh
- BJP leader Krishna Sagar Rao condoles death of former PM Manmohan Singh
- Sirivella: Engg student dies in accident
Hyderabad: Balaxi Pharma posts Rs 10 crore net in Q2
Balaxi Pharma posts Rs 10 crore net in Q2
City-based Balaxi Pharmaceuticals Limited (BPL) reported Rs 60.3 crore revenue for the second quarter ended September 2020
Hyderabad: City-based Balaxi Pharmaceuticals Limited (BPL) reported Rs 60.3 crore revenue for the second quarter ended September 2020. It reported an EBITDA of Rs 10.3 crore and a net profit of Rs 10.1 crore during the period.
During the first half of current fiscal, it posted a total revenue of Rs 112.4 crore. The EBITDA stood Rs 19.3 crore while net profit came at Rs 18.8 crore. Ashish Maheshwari, company's Chairman and Managing Director, said: "We are delighted to report a decent growth in our business amidst Covid-19 pandemic.
The company has 548 pharmaceutical product registrations spanning across five countries and 582 product registrations in pipeline.
We also have a well-established expert regulatory team, which carefully monitors the registration process at every stage. We aim to double our pharmaceutical product registrations over next 2 years."
